Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Video: Sitting Down With… Delara Motlagh
Fujifilm Cellular Dynamics’ Delara Motlagh discusses her path into cell and gene therapy, the challenges of scaling manufacturing, and the potential of iPSC technologies
The video interview discusses Delara Motlagh’s career, leadership, manufacturing challenges, iPSCs, and the roles of CDMOs and technology providers in making advanced therapies more accessible.
Approach:
Format: Video interview produced in partnership with IBTV.
Topics: Motlagh discusses leadership, complex manufacturing challenges, induced pluripotent stem cells (iPSCs), and the roles of CDMOs and technology providers.
Key Findings:
Delara Motlagh is Chief Operating Officer at Fujifilm Cellular Dynamics.
Motlagh discusses her career and the evolution of cell and gene therapy over more than two decades.
Interpretation:
The interview focuses on Motlagh’s career and perspectives on iPSC research and therapeutics, manufacturing, and access to advanced therapies.
Limitations:
The provided context does not include the full interview or specific examples and detailed claims.
Patients restarting therapy within 1 day showed no statistically significant adjusted differences in sinonasal healing, bleeding, or patient-reported outcomes.
